Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells-Reference-Cited by-同舟云学术

Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells

Published:2021-09 Issue:9 Volume:23 Page:810-819
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Xing Haiyan,Yang Xue,Xu Yingxi,Tang Kejing,Tian Zheng,Chen Zhaoqi,Zhang Yu,Xue Zhenya,Rao Qing,Wang Min,Wang Jianxiang

Funder

Chinese Academy of Medical Sciences

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference44 articles.

1. Clinical applications of angiogenic growth factors and their inhibitors;Ferrara;Nature medicine,1999

2. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3;Makinen;Nature medicine,2001

3. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis;Mandriota;The EMBO journal,2001

4. Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice;Muchowicz;Eur J Cancer,2017

5. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2;Roberts;Cancer research,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor vasculature associated nanomedicine strategies;Coordination Chemistry Reviews;2024-12

2. CAR-T cell technologies that interact with the tumour microenvironment in solid tumours;Expert Review of Clinical Immunology;2024-07-17

3. Mechanoimmunology in the solid tumor microenvironment;Biochemical Society Transactions;2024-06-10

4. CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies;Frontiers in Immunology;2024-04-12

5. Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances;Journal of Controlled Release;2024-04